Other Solid Tumors Recruiting Phase 1 Trials for Pembrolizumab (DB09037)

Also known as: Other Solid Tumor

IndicationStatusPhase
DBCOND0030393 (Other Solid Tumors)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03329950A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced MalignanciesTreatment